Key regions: Australia, United States, India, Europe, China
The Digestive & Intestinal Remedies (Pharmacies) market in Malawi has experienced significant growth in recent years, driven by changing customer preferences and local special circumstances. Customer preferences in the market have shifted towards natural and herbal remedies, as consumers seek alternatives to traditional pharmaceutical products. This trend is in line with global and regional market developments, as consumers become more conscious of their health and seek out products that are perceived as more natural and less harmful. This preference for natural remedies has led to an increase in the demand for herbal digestive and intestinal remedies in Malawi. In addition to changing customer preferences, local special circumstances have also contributed to the growth of the Digestive & Intestinal Remedies market in Malawi. The country has a high prevalence of gastrointestinal diseases, including diarrhea and dysentery, which has created a significant demand for remedies to alleviate these conditions. The lack of access to clean water and sanitation facilities in many parts of the country has contributed to the high incidence of these diseases, making digestive and intestinal remedies a necessity for many Malawians. Furthermore, the government of Malawi has taken steps to improve healthcare infrastructure and increase access to healthcare services, including pharmaceutical products. This has led to an expansion of the pharmacy sector in the country, with more pharmacies opening up to meet the growing demand for healthcare products. The increased availability of pharmacies has made it easier for consumers to access digestive and intestinal remedies, further fueling the growth of the market. Underlying macroeconomic factors, such as population growth and increasing disposable incomes, have also played a role in the development of the Digestive & Intestinal Remedies market in Malawi. The country has a rapidly growing population, which has resulted in an increased demand for healthcare products and services. Additionally, rising disposable incomes have allowed more Malawians to afford healthcare products, including digestive and intestinal remedies. In conclusion, the Digestive & Intestinal Remedies market in Malawi has experienced growth due to changing customer preferences towards natural remedies, local special circumstances such as high prevalence of gastrointestinal diseases, government initiatives to improve healthcare infrastructure, and underlying macroeconomic factors such as population growth and increasing disposable incomes. These factors have created a favorable market environment for the growth of the Digestive & Intestinal Remedies market in Malawi.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
